KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
2.430
-0.170 (-6.54%)
At close: May 22, 2026, 4:00 PM EDT
2.440
+0.010 (0.41%)
After-hours: May 22, 2026, 7:37 PM EDT
KALA BIO Employees
KALA BIO had 6 employees as of December 31, 2025. The number of employees decreased by 32 or -84.21% compared to the previous year.
Employees
6
Change (1Y)
-32
Growth (1Y)
-84.21%
Revenue / Employee
n/a
Profits / Employee
-$3,275,667
Market Cap
45.17M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | -32 | -84.21% |
| Dec 31, 2024 | 38 | -5 | -11.63% |
| Dec 31, 2023 | 43 | 9 | 26.47% |
| Dec 31, 2022 | 34 | -158 | -82.29% |
| Dec 31, 2021 | 192 | 4 | 2.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Metagenomi Therapeutics | 119 |
| Xilio Therapeutics | 76 |
| aTyr Pharma | 60 |
| Mereo BioPharma Group | 39 |
| Plus Therapeutics | 28 |
| Tevogen Bio Holdings | 18 |
| Atossa Therapeutics | 16 |
KALA News
- 10 days ago - KALA BIO Quarterly report: Q1 2026 - Filings
- 13 days ago - Kala Bio falls -21.7% - TheFly
- 18 days ago - Kala Bio files $350M mixed securities shelf - TheFly
- 18 days ago - Kala Bio announces reverse stock split - TheFly
- 18 days ago - KALA BIO Announces Reverse Stock Split - GlobeNewsWire
- 18 days ago - KALA BIO Registration statement: Registration filing - Filings
- 4 weeks ago - Kala Bio ‘celebrates’ U.S. Executive Order for psychedelic medicine - TheFly
- 4 weeks ago - Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine - GlobeNewsWire